Simple exploration of 212327-10-1

212327-10-1, The synthetic route of 212327-10-1 has been constantly updated, and we look forward to future research findings.

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.212327-10-1,7-Bromo-2-methoxyquinoxaline,as a common compound, the synthetic route is as follows.

0306] To a solution of 7-bromo-2-methoxyquinoxaline (24.1 g, 100 mmol, 1 eq.) in DMF (50 mL) and EtOH ( 250 mL ) was added NaOAc (32.8 g, 400 mmol, 4 eq.) and Pd(dppf)Cl2 (1.63 g, 2 mmol, 0.02 eq) under N2 protection. The resulting mixture was stirred at 90 C under CO (3 MPa) overnight, then cooled to rt, filtered and concentrated to afford crude ethyl 3-methoxyquinoxaline-6- carboxylate as a brown solid (23.2 g, 100%) which used in next step without further purification

212327-10-1, The synthetic route of 212327-10-1 has been constantly updated, and we look forward to future research findings.

Reference£º
Patent; NEUPHARMA, INC.; QIAN, Xiangping; ZHU, Yong-liang; WO2013/40515; (2013); A1;,
Quinoxaline – Wikipedia
Quinoxaline | C8H6N2 | ChemSpider